Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Gruber, G; Cole, B F; Castiglione-Gertsch, M; Holmberg, S B; Lindtner, J; Golouh, R; Collins, J; Crivellari, D; Thürlimann, B; Simoncini, E; Fey, M F; Gelber, R D; Coates, A S; Price, K N; Goldhirsch, A; Viale, G; Gusterson, B A; International Breast Cancer Study Group
2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Regan, M M; Pagani, O; Walley, B; Torrisi, R; Perez, E A; Francis, P; Fleming, G F; Price, K N; Thürlimann, B; Maibach, R; Castiglione-Gertsch, M; Coates, A S; Goldhirsch, A; Gelber, R D; SOFT/TEXT/PERCHE Steering Committee; International Breast Cancer Study Group
2008
Premenopausal endocrine-responsive early breast cancer : who receives chemotherapy?
Viale, G; Regan, M M; Dell'Orto, P; Mastropasqua, M G; Maiorano, E; Rasmussen, B B; MacGrogan, G; Forbes, J F; Paridaens, R J; Colleoni, M; Láng, I; Thürlimann, B; Mouridsen, H; Mauriac, L; Gelber, R D; Price, K N; Goldhirsch, A; Gusterson, B A; Coates, A S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2011
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J-M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
Annals of oncology : official journal of the European Society for Medical Oncology
Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A; International Breast Cancer Study Group
2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
Annals of oncology : official journal of the European Society for Medical Oncology
Regan, Meredith M; Price, Karen N; Giobbie-Hurder, Anita; Thürlimann, Beat; Gelber, Richard D; International Breast Cancer Study Group and BIG 1-98 Collaborative Group
2011
Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
Paridaens, Robert J; Gelber, Shari; Cole, Bernard F; Gelber, Richard D; Thürlimann, Beat; Price, Karen N; Holmberg, Stig B; Crivellari, Diana; Coates, Alan S; Goldhirsch, Aron
2010
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
Thürlimann, Beat; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Crivellari, Diana; Colleoni, Marco; Collins, John; Forbes, John F; Castiglione-Gertsch, Monica; Coates, Alan S; Goldhirsch, Aron
2009
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
Chirgwin, Jacquie; Sun, Zhuoxin; Smith, Ian; Price, Karen N; Thürlimann, Beat; Ejlertsen, Bent; Bonnefoi, Hervé; Regan, Meredith M; Goldhirsch, Aron; Coates, Alan S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2012
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
Pagani, Olivia; Price, Karen N; Gelber, Richard D; Castiglione-Gertsch, Monica; Holmberg, Stig B; Lindtner, Jurij; Thürlimann, Beat; Collins, John; Fey, Martin F; Coates, Alan S; Goldhirsch, Aron; International Breast Cancer Study Group (IBCSG)
2009
Patterns of recurrence of early breast cancer according to estrogen receptor status : a therapeutic target for a quarter of a century
Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin F; Murray, Elizabeth; Forbes, John F; Coates, Alan S; Goldhirsch, Aron; International Breast Cancer Study Group
2009
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S; International Breast Cancer Study Group
2008
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
Strasser, Florian; Lutz, Thomas A.; Maeder, Micha T.; Thuerlimann, Beat; Buechel, David; Tschöp, Matthias H.; Kaufmann, Katrin; Holst, B.; Brändle, Michael; von Moos, Roger; Demmer, Ruth; Cerny, Thomas
2008
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
